Galectin Therapeutics (GALT)
(Delayed Data from NSDQ)
$2.65 USD
+0.02 (0.76%)
Updated Sep 26, 2024 03:59 PM ET
After-Market: $2.65 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value C Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Galectin Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -41.07 | -38.78 | -30.53 | -23.47 | -13.29 |
Depreciation/Amortization & Depletion | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 |
Net Change from Assets/Liabilities | 4.68 | 4.97 | 3.75 | 0.94 | 0.64 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 3.39 | 2.72 | 2.43 | 1.89 | 1.77 |
Net Cash From Operating Activities | -32.97 | -31.06 | -24.31 | -20.60 | -10.85 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 10.03 | 0.00 | 6.81 | 0.26 | 50.47 |
Issuance (Repayment) of Debt | 30.00 | 10.00 | 30.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | -0.39 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 40.03 | 10.00 | 36.81 | 0.26 | 50.08 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 7.07 | -21.06 | 12.51 | -20.34 | 39.23 |
Cash at Beginning of Period | 18.59 | 39.65 | 27.14 | 47.48 | 8.25 |
Cash at End of Period | 25.66 | 18.59 | 39.65 | 27.14 | 47.48 |
Diluted Net EPS | -0.74 | -0.65 | -0.52 | -0.41 | -0.39 |
Fiscal Year End for Galectin Therapeutics Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -23.86 | -11.49 | -41.07 | -31.07 | -20.64 |
Depreciation/Amortization & Depletion | 0.02 | 0.01 | 0.03 | 0.02 | 0.02 |
Net Change from Assets/Liabilities | 0.84 | -2.31 | 4.68 | -0.26 | -1.77 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 2.56 | 1.68 | 3.39 | 3.04 | 1.77 |
Net Cash From Operating Activities | -20.44 | -12.11 | -32.97 | -28.26 | -20.63 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.38 | 0.00 | 10.03 | 10.03 | 0.00 |
Issuance (Repayment) of Debt | 20.00 | 10.00 | 30.00 | 20.00 | 20.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 20.38 | 10.00 | 40.03 | 30.03 | 20.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -0.06 | -2.11 | 7.07 | 1.77 | -0.63 |
Cash at Beginning of Period | 25.66 | 25.66 | 18.59 | 18.59 | 18.59 |
Cash at End of Period | 25.60 | 23.56 | 25.66 | 20.36 | 17.97 |
Diluted Net EPS | -0.20 | -0.19 | -0.16 | -0.24 | -0.15 |